These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
5. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies. Kastango ES JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322 [TBL] [Abstract][Full Text] [Related]
6. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report. World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103 [No Abstract] [Full Text] [Related]
8. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Hyde TD Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341 [TBL] [Abstract][Full Text] [Related]
9. USP publishes enforceable chapter on sterile compounding. Thompson CA Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028 [No Abstract] [Full Text] [Related]
10. Protecting consumers from counterfeit drugs. FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838 [No Abstract] [Full Text] [Related]
11. Quality Assurance and Quality Control, Part 2. Akers MJ Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362 [TBL] [Abstract][Full Text] [Related]
12. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations]. Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280 [TBL] [Abstract][Full Text] [Related]
13. Clarifications on the Intended Use of USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests. Tidswell EC; Tirumalai RS; Gross DD PDA J Pharm Sci Technol; 2024 Jun; 78(3):348-357. PubMed ID: 38942475 [TBL] [Abstract][Full Text] [Related]
14. Development of the antimicrobial effectiveness test as USP chapter <51>. Sutton SV; Porter D PDA J Pharm Sci Technol; 2002; 56(6):300-11. PubMed ID: 12497767 [TBL] [Abstract][Full Text] [Related]
15. Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities. Weller T; Kragseth R; Dullinger R; Illum H; Perry A Int J Pharm Compd; 2015; 19(3):182-92. PubMed ID: 26714359 [TBL] [Abstract][Full Text] [Related]
16. Influence of compounding on sterility and stability of drugs. Hardee GE J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582 [No Abstract] [Full Text] [Related]
17. Establishing powder-handling workflow practices and standard operating procedures: compounding pharmacy and safety. Prince B; Lundevall J Int J Pharm Compd; 2014; 18(3):222-6. PubMed ID: 25306770 [TBL] [Abstract][Full Text] [Related]
18. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program. Griffiths T; Connors A Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174 [TBL] [Abstract][Full Text] [Related]
19. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding. Ligugnana R Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779 [TBL] [Abstract][Full Text] [Related]
20. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]